Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNTX-4975 in Painful Intermetatarsal Neuroma
NCT02283957Phase 2Completed
- Sponsor
- Centrexion Therapeutics
- Start
- Oct 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of capsaicin in Morton's neuroma (4 arms), sponsored by Centrexion Therapeutics. Primary endpoint: Change from Baseline in average neuroma foot pain (Diary) with walking using the NPRS at 4 weeks. Started Oct 2014; status: completed.
02
Drugs
capsaicin
03
Conditions
Morton's neuroma
Beyond the preview
Go deeper on NCT02283957.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02283957.